These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 29077674)

  • 1. Macrophage Activation and the Tumor Necrosis Factor Cascade in Hepatitis C Disease Progression Among HIV-Infected Women Participating in the Women's Interagency HIV Study.
    French AL; Martin JW; Evans CT; Peters M; Kessaye SG; Nowicki M; Kuniholm M; Golub E; Augenbraun M; Desai SN;
    J Acquir Immune Defic Syndr; 2017 Dec; 76(4):438-444. PubMed ID: 29077674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microbial translocation and liver disease progression in women coinfected with HIV and hepatitis C virus.
    French AL; Evans CT; Agniel DM; Cohen MH; Peters M; Landay AL; Desai SN
    J Infect Dis; 2013 Aug; 208(4):679-89. PubMed ID: 23687224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV Infection, HCV Coinfection, and Alcohol Use: Associations with Microbial Translocation and Immune Activation.
    Monnig MA; Cohen R; Ramratnam B; McAdams M; Tashima K; Monti PM
    Alcohol Clin Exp Res; 2019 Jun; 43(6):1126-1134. PubMed ID: 30908642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolated Hepatitis B Core Antibody Status Is Not Associated With Accelerated Liver Disease Progression in HIV/Hepatitis C Coinfection.
    French AL; Hotton A; Young M; Nowicki M; Augenbraun M; Anastos K; Seaberg E; Rosenberg W; Peters MG
    J Acquir Immune Defic Syndr; 2016 Jul; 72(3):274-80. PubMed ID: 26918547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreases in markers of monocyte/macrophage activation after hepatitis C eradication in HIV/hepatitis C virus coinfected women.
    French AL; Grennan D; Daubert E; Seaberg EC; Peters M; Augenbraun M; Fischl M; Kassaye S; Franco R; Kuniholm M; Adimora AA; Workowski K; Weber KM
    AIDS; 2021 Jul; 35(9):1433-1438. PubMed ID: 33710024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Active HCV infection is associated with increased circulating levels of interferon-gamma (IFN-γ)-inducible protein-10 (IP-10), soluble CD163 and inflammatory monocytes regardless of liver fibrosis and HIV coinfection.
    Mascia C; Lichtner M; Zuccalà P; Vita S; Tieghi T; Marocco R; Savinelli S; Rossi R; Iannetta M; Campagna M; Schiavone F; Mengoni F; Russo G; Mastroianni CM; Vullo V
    Clin Res Hepatol Gastroenterol; 2017 Dec; 41(6):644-655. PubMed ID: 28578937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-6 is associated with noninvasive markers of liver fibrosis in HIV-infected patients with alcohol problems.
    Fuster D; Tsui JI; Cheng DM; Quinn EK; Armah KA; Nunes D; Freiberg MS; Samet JH
    AIDS Res Hum Retroviruses; 2013 Aug; 29(8):1110-6. PubMed ID: 23601055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macrophage Activation Marker Soluble CD163 Is a Dynamic Marker of Liver Fibrogenesis in Human Immunodeficiency Virus/Hepatitis C Virus Coinfection.
    Lidofsky A; Holmes JA; Feeney ER; Kruger AJ; Salloum S; Zheng H; Seguin IS; Altinbas A; Masia R; Corey KE; Gustafson JL; Schaefer EA; Hunt PW; Deeks S; Somsouk M; Chew KW; Chung RT; Alatrakchi N
    J Infect Dis; 2018 Sep; 218(9):1394-1403. PubMed ID: 29868909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic inflammation and liver damage in HIV/hepatitis C virus coinfection.
    Shmagel KV; Saidakova EV; Shmagel NG; Korolevskaya LB; Chereshnev VA; Robinson J; Grivel JC; Douek DC; Margolis L; Anthony DD; Lederman MM
    HIV Med; 2016 Sep; 17(8):581-9. PubMed ID: 27187749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic fibrosis and immune phenotype vary by HCV viremia in HCV/HIV co-infected subjects: A Women's interagency HIV study.
    Desai SN; Dodge JL; Landay AL; Glesby MJ; Latham PS; Villacres MC; French AL; Gange SJ; Greenblatt RM; Peters MG
    Medicine (Baltimore); 2016 Aug; 95(33):e4483. PubMed ID: 27537569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. During Hepatitis C Virus (HCV) Infection and HCV-HIV Coinfection, an Elevated Plasma Level of Autotaxin Is Associated With Lysophosphatidic Acid and Markers of Immune Activation That Normalize During Interferon-Free HCV Therapy.
    Kostadinova L; Shive CL; Judge C; Zebrowski E; Compan A; Rife K; Hirsch A; Falck-Ytter Y; Schlatzer DM; Li X; Chance MR; Rodriguez B; Popkin DL; Anthony DD
    J Infect Dis; 2016 Nov; 214(9):1438-1448. PubMed ID: 27540113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune activation response in chronic HIV-infected patients: influence of Hepatitis C virus coinfection.
    Márquez M; Romero-Cores P; Montes-Oca M; Martín-Aspas A; Soto-Cárdenas MJ; Guerrero F; Fernández-Gutiérrez C; Girón-González JA
    PLoS One; 2015; 10(3):e0119568. PubMed ID: 25775475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contribution of Liver Fibrosis and Microbial Translocation to Immune Activation in Persons Infected With HIV and/or Hepatitis C Virus.
    Reid M; Ma Y; Scherzer R; Price JC; French AL; Huhn GD; Plankey MW; Peters M; Grunfeld C; Tien PC
    J Infect Dis; 2018 Mar; 217(8):1289-1297. PubMed ID: 29304196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macrophage inflammatory markers are associated with subclinical carotid artery disease in women with human immunodeficiency virus or hepatitis C virus infection.
    Shaked I; Hanna DB; Gleißner C; Marsh B; Plants J; Tracy D; Anastos K; Cohen M; Golub ET; Karim R; Lazar J; Prasad V; Tien PC; Young MA; Landay AL; Kaplan RC; Ley K
    Arterioscler Thromb Vasc Biol; 2014 May; 34(5):1085-92. PubMed ID: 24651679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune activation and microbial translocation in liver disease progression in HIV/hepatitis co-infected patients: results from the Icona Foundation study.
    Marchetti G; Cozzi-Lepri A; Tincati C; Calcagno A; Ceccherini-Silberstein F; De Luca A; Antinori A; Castagna A; Puoti M; Monforte Ad;
    BMC Infect Dis; 2014 Feb; 14():79. PubMed ID: 24520976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver fibrosis progression and clinical outcomes are intertwined: role of CD4+ T-cell count and NRTI exposure from a large cohort of HIV/HCV-coinfected patients with detectable HCV-RNA: A MASTER cohort study.
    Focà E; Fabbiani M; Prosperi M; Quiros Roldan E; Castelli F; Maggiolo F; Di Filippo E; Di Giambenedetto S; Gagliardini R; Saracino A; Di Pietro M; Gori A; Sighinolfi L; Pan A; Postorino MC; Torti C;
    Medicine (Baltimore); 2016 Jul; 95(29):e4091. PubMed ID: 27442636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibrosis Progression in Paired Liver Biopsies from HIV/HCV-Coinfected Patients without Prior Treatment of Hepatitis C.
    Leite AG; Duarte MI; Mendes-Correa MC
    J Int Assoc Provid AIDS Care; 2015; 14(5):463-8. PubMed ID: 26056147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver cirrhosis in HIV/HCV-coinfected individuals is related to NK cell dysfunction and exhaustion, but not to an impaired NK cell modulation by CD4
    Polo ML; Ghiglione YA; Salido JP; Urioste A; Poblete G; Sisto AE; Martinez A; Rolón MJ; Ojeda DS; Cahn PE; Turk GJ; Laufer NL
    J Int AIDS Soc; 2019 Sep; 22(9):e25375. PubMed ID: 31536177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progression of liver fibrosis in HIV/hepatitis C virus-coinfected individuals on antiretroviral therapy with early stages of liver fibrosis at baseline.
    Sanmartín R; Tor J; Sanvisens A; López JJ; Jou A; Muga R; Ojanguren I; Barluenga E; Videla S; Planas R; Clotet B; Tural C
    HIV Med; 2014 Apr; 15(4):203-12. PubMed ID: 24245909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemical non-invasive assessment of liver fibrosis cannot replace biopsy in HIV-HCV coinfected patients.
    Kliemann DA; Wolff FH; Tovo CV; Alencastro PR; Ikeda ML; Brandão AB; Barcellos N; Fuchs SC
    Ann Hepatol; 2016; 15(1):27-32. PubMed ID: 26626637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.